REYNOLDS W ANN

SEC source: 0001104659-09-026810 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,859

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-028091 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,394

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-08-022158 · a4.xml · derivative · entry 11

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 5,124 shares

Expires 2008-04-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program.

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 8

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,477

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 7

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,151

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 6

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,851

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 5

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,751

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 4

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,051

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 3

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,301

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 2

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,501

SEC source: 0001104659-08-022158 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,601

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-058452 · a4.xml · derivative · entry 7

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 2,881 shares

Expires 2007-10-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-058452 · a4.xml · derivative · entry 6

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 1,436 shares

Expires 2007-09-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-058452 · a4.xml · nonDerivative · entry 3

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,477

SEC source: 0001104659-07-058452 · a4.xml · nonDerivative · entry 2

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-058452 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,168

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-034473 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,732

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-07-003715 · a4.xml · derivative · entry 5

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 1,383 shares

Expires 2007-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-003715 · a4.xml · nonDerivative · entry 2

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,002

SEC source: 0001104659-07-003715 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,385

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-001053 · a4.xml · derivative · entry 5

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 1,617 shares

Expires 2007-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-001053 · a4.xml · nonDerivative · entry 2

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,002

SEC source: 0001104659-07-001053 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,619

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-06-049373 · a4.xml · derivative · entry 5

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 1,796 shares

Expires 2006-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-06-049373 · a4.xml · nonDerivative · entry 2

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,002

SEC source: 0001104659-06-049373 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,798

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-06-048259 · a4.xml · derivative · entry 5

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 1,870 shares

Expires 2006-09-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-06-048259 · a4.xml · nonDerivative · entry 2

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,002

SEC source: 0001104659-06-048259 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,872

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-06-030320 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,002

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-06-000355 · a4.xml · derivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,432

Underlying: common shares · 583 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001104659-05-046915 · a4.xml · derivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,778

Underlying: common shares · 542 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001104659-05-031010 · a4.xml · derivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,175

Underlying: common shares · 469 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001104659-05-018224 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,875

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid in Abbott common shares, on a one-to-one basis, on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-04-012719 · a4.xml · derivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,446

Underlying: common shares · 4,132 shares

Expires not disclosed

F1 · derivative.exercise_price: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash.

F1 · kind: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash.

F1 · derivative.exercise_date: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash.

F1 · derivative.expiration_date: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001104659-04-011394 · a4.xml · derivative · entry 4

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,699

Underlying: common shares · 6,699 shares

Expires 2014-04-22

F4 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b). It contains a replacement option feature.

SEC source: 0001104659-04-011394 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,986

F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.